2024-11-19 06:32:09
Author: China Literature / 2023-07-23 23:18 / Source: China Literature

China Literature to Report First Half 2021 Financial Results on August 16, 2021

HONG KONG,July 21,2021 -- China Literature Limited ("China Literature" or "the Company",0772.HK),a leading online literature and intellectual property ("IP") incubation platform in China,will announce its financial results for the first half of 2021 on Monday,August 16,2021.

The results announcement will be available on China Literature's investor relations website at http://ir.yuewen.com.

China Literature's management team will host a conference call to present an overview of the Company's financial performance and business operations. A live webcast of the call can be accessed on the Company's investor relations website.

Details of the conference call and webcast are as follows:

Time: 8:00 pm (Hong Kong Time) / 8:00 am (U.S. Eastern Time)


Language: English


Webcast: https://ir-api.yuewen.com/calendar/WebcastsCalls/1H2021


Dial-in Numbers:


U.S.: +1 347 549 4094


Hong Kong: +852 3018 8307


Mainland China (Landline): 800 820 2079


Mainland China: 400 820 6895


U.K.: +44 20 3713 5084


International: +65 6713 5330


Conference ID: 3867105

A replay of the conference call will be available from 11:00 pm (Hong Kong Time) on August 16,2021 for 7 days.

U.S.: +1 646 254 3697


Hong Kong: +852 3051 2780


International: +61 2 8199 0299


Conference ID: 3867105

Archived webcast will be available at the same link above.

Contact:

For investors / analysts:


Maggie Zhou


Tel: +8621 6187 0500 ext. 80605


Email:IR@yuewen.com

For media:


Vivian Wang


Tel: +852 2232 3978


Email: vwang@Christensenir.com

Tags: Computer/Electronics Multimedia/Online/Internet Publishing/Information Service

Previous:

Next:

Leave a comment

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release